SCHEMBL17424240

SCHEMBL17424240

B[C@H]1[C@@H](O)[C@H](c2cn(C)c(=O)n(C)c2=O)O[C@@H]1CCP(=C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17463503 0.90 SLC5A1 (0.32) —
SCHEMBL14945996 0.90 SLC5A1 (0.32) —
SCHEMBL14928761 0.90 SLC5A1 (0.32) —
SCHEMBL15249044 0.90 SLC5A1 (0.32) —
SCHEMBL18118104 0.90 SLC5A1 (0.32) —
SCHEMBL15249043 0.74 — —
SCHEMBL17463521 0.74 — —
SCHEMBL15305383 0.74 NNMT (0.30) —
SCHEMBL21082362 0.73 SLC5A2 (0.36) —
SCHEMBL17210983 0.73 SLC5A2 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9233141-B2 Modified polynucleotides for the production of proteins associated with blood and lymphatic disorders MODERNA THERAPEUTICS, INC. (US) 2016-01-12 — — US disclosed
Send feedback